Terms: = Breast cancer AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1 AND Prognosis
77 results:
1. Neuropilin-1 and placental growth factor as prognostic factors in metastatic breast cancer.
Mäenpää N; Tiainen L; Hämäläinen M; Luukkaala T; Tanner M; Lahdenperä O; Vihinen P; Karihtala P; Kellokumpu-Lehtinen PL; Moilanen E; Jukkola A
BMC Cancer; 2024 Mar; 24(1):331. PubMed ID: 38468231
[TBL] [Abstract] [Full Text] [Related]
2. Clinical significance and immune characteristics analysis of miR-221-3p and its key target genes related to epithelial-mesenchymal transition in breast cancer.
Fang Y; Zhang Q; Chen Z; Guo C; Wu J
Aging (Albany NY); 2024 Jan; 16(1):322-347. PubMed ID: 38189813
[TBL] [Abstract] [Full Text] [Related]
3. The Relation of VEGFA, vegfr2, VEGI, and HIF1A Genetic Variants and Their Serum Protein Levels with breast cancer in Egyptian Patients.
Abdelgalil AA; Monir R; Elmetwally M; Ghattas MH; Bazeed FB; Mesbah NM; Abo-Elmatty DM; Mehanna ET
Biochem Genet; 2024 Feb; 62(1):547-573. PubMed ID: 37392242
[TBL] [Abstract] [Full Text] [Related]
4. Recent Advances in Therapeutic Modalities Against breast cancer-Related Lymphedema: Future Epigenetic Landscape.
Chen K; Beeraka NM; Zhang X; Sinelnikov MY; Plotnikova M; Zhao C; Basavaraj V; Zhang J; Lu P
Lymphat Res Biol; 2023 Dec; 21(6):536-548. PubMed ID: 37267206
[No Abstract] [Full Text] [Related]
5. Evaluation of the in vitro and in vivo effect of liposomal doxorubicin along with oncolytic Newcastle disease virus on 4T1 cell line: Animal preclinical research.
Faranoush P; Jahandideh A; Nekouian R; Mortazavi P
Vet Med Sci; 2023 May; 9(3):1426-1437. PubMed ID: 36920334
[TBL] [Abstract] [Full Text] [Related]
6. Mammary mucinous cystadenocarcinoma with long-term follow-up: molecular information and literature review.
Lei T; Shi YQ; Chen TB
Diagn Pathol; 2023 Feb; 18(1):13. PubMed ID: 36737820
[TBL] [Abstract] [Full Text] [Related]
7. Histopathologic Grading Is of Prognostic Significance in Primary Angiosarcoma of breast: Proposal of a Simplified 2-tier Grading System.
Kuba MG; Dermawan JK; Xu B; Singer S; Plitas G; Tap WD; D'Angelo SP; Rosenbaum E; Brogi E; Antonescu CR
Am J Surg Pathol; 2023 Mar; 47(3):307-317. PubMed ID: 36376999
[TBL] [Abstract] [Full Text] [Related]
8. Mutational landscape of primary breast angiosarcoma with repeated resection and recurrence over a 15-year period: A case report.
Teruyama F; Kuno A; Murata Y; Nakagawa T; Shiba-Ishii A; Yuguchi S; Noguchi M
Pathol Int; 2022 Sep; 72(9):457-463. PubMed ID: 35801418
[TBL] [Abstract] [Full Text] [Related]
9. Biomarker Profiling Revealed Carcinoembryonic Antigen as a Target of Artesunate in a Ductal breast cancer Patient.
Saeed MEM; Drif AI; Efferth T
Anticancer Res; 2022 Jul; 42(7):3483-3494. PubMed ID: 35790273
[TBL] [Abstract] [Full Text] [Related]
10. Clinical Significance of Major Angiogenesis-Related Effectors in Patients with Metastatic breast cancer Treated with Trastuzumab-Based Regimens.
Kourea HP; Dimitrakopoulos FI; Koliou GA; Batistatou A; Papadopoulou K; Bobos M; Asimaki-Vlachopoulou A; Chrisafi S; Pavlakis K; Chatzopoulos K; Galani E; Pentheroudakis G; Pectasides D; Bafaloukos D; Res E; Papakostas P; Koutras A; Kotoula V; Fountzilas G
Cancer Res Treat; 2022 Oct; 54(4):1053-1064. PubMed ID: 34793664
[TBL] [Abstract] [Full Text] [Related]
11. IQ Motif-Containing GTPase-Activating Protein 2 Inhibits breast cancer Angiogenesis by Suppressing vegfr2-AKT Signaling.
Kumar D; Patel SA; Khan R; Chawla S; Mohapatra N; Dixit M
Mol Cancer Res; 2022 Jan; 20(1):77-91. PubMed ID: 34615693
[TBL] [Abstract] [Full Text] [Related]
12. Molecular features of untreated breast cancer and initial metastatic event inform clinical decision-making and predict outcome: long-term results of ESOPE, a single-arm prospective multicenter study.
Callens C; Driouch K; Boulai A; Tariq Z; Comte A; Berger F; Belin L; Bièche I; Servois V; Legoix P; Bernard V; Baulande S; Chemlali W; Bidard FC; Fourchotte V; Salomon AV; Brain E; Lidereau R; Bachelot T; Saghatchian M; Campone M; Giacchetti S; Zafrani BS; Cottu P
Genome Med; 2021 Mar; 13(1):44. PubMed ID: 33722295
[TBL] [Abstract] [Full Text] [Related]
13. miR-34a and miR-200c Have an Additive Tumor-Suppressive Effect on breast cancer Cells and Patient prognosis.
Mansoori B; Silvestris N; Mohammadi A; Khaze V; Baghbani E; Mokhtarzadeh A; Shanehbandi D; Derakhshani A; Duijf PHG; Baradaran B
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33673143
[TBL] [Abstract] [Full Text] [Related]
14. Orbital metastases from breast cancer: A retrospective analysis of 28 cases.
Grajales-Alvarez R; Gutierrez-Mata A
Cancer Treat Res Commun; 2020; 24():100184. PubMed ID: 32575027
[TBL] [Abstract] [Full Text] [Related]
15. A Novel Multimodal Therapy for Anaplastic Thyroid Carcinoma:
Niu Y; Ding Z; Deng X; Guo B; Kang J; Wu B; Fan Y
Front Endocrinol (Lausanne); 2020; 11():207. PubMed ID: 32390940
[TBL] [Abstract] [Full Text] [Related]
16. Relationship between SDC1 and cadherin signalling activation in cancer.
Liao S; Liu C; Zhu G; Wang K; Yang Y; Wang C
Pathol Res Pract; 2020 Jan; 216(1):152756. PubMed ID: 31810587
[TBL] [Abstract] [Full Text] [Related]
17. Genetic interactions between ANLN and kdr are prognostic for breast cancer survival.
Dai X; Chen X; Hakizimana O; Mei Y
Oncol Rep; 2019 Dec; 42(6):2255-2266. PubMed ID: 31578580
[TBL] [Abstract] [Full Text] [Related]
18. Apelin inhibition prevents resistance and metastasis associated with anti-angiogenic therapy.
Uribesalgo I; Hoffmann D; Zhang Y; Kavirayani A; Lazovic J; Berta J; Novatchkova M; Pai TP; Wimmer RA; László V; Schramek D; Karim R; Tortola L; Deswal S; Haas L; Zuber J; Szűcs M; Kuba K; Dome B; Cao Y; Haubner BJ; Penninger JM
EMBO Mol Med; 2019 Aug; 11(8):e9266. PubMed ID: 31267692
[TBL] [Abstract] [Full Text] [Related]
19. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/vegfr2/ERK pathway.
Zhang Q; Lu S; Li T; Yu L; Zhang Y; Zeng H; Qian X; Bi J; Lin Y
J Exp Clin Cancer Res; 2019 Apr; 38(1):173. PubMed ID: 31023337
[TBL] [Abstract] [Full Text] [Related]
20. Serum Biomarkers for Racial Disparities in breast cancer Progression.
Srivastava M; Eidelman O; Craig J; Starr J; Kvecher L; Liu J; Hueman M; Pollard HB; Hu H; Shriver CD
Mil Med; 2019 Mar; 184(Suppl 1):652-657. PubMed ID: 30901475
[TBL] [Abstract] [Full Text] [Related]
[Next]
